Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLASTIC-3: FAPI-PET/CT for Staging Gastric Cancer
NCT07018661Phase 3Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Jul 2025
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of [18F]-FAPI-74 in gastric cancer (GC), sponsored by Leiden University Medical Center. Primary endpoints: Change in treatment intent at 1 year and Change in diagnostic work-up. Started Jul 2025; status: recruiting.
02
Drugs
[18F]-FAPI-74
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT07018661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07018661.